Skip to main content
    A

    Arcus Biosciences Inc (RCUS)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NYSE

    $16.40
    -0.46 (-2.73%)

    Market Cap: $2.43B

    Last updated: Nov 17, 2026 at 4:20 PM ET

    Arcus Biosciences Inc (RCUS) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Arcus Biosciences (RCUS) has a latest price of $16.40 on Nov 17, 2026. Its price fell 18.3% over the past 12 months. The month-end price rose 17.8% since Mar 2018, a compound annual rate of 1.9%.

    Price Chart

    From Mar 2018 to Oct 2026, its highest month-end close was $43.80 in Nov 2021 and its lowest $7.81 in Aug 2019, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart RCUS with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for RCUS.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 46.0%, and over 6 months it fell 27.9%. The month-end price rose 15.8% over the 3 years through Oct 2026, a compound annual rate of 5.0%.

    PeriodChange
    1 month-25.9%
    3 months-46.0%
    6 months-27.9%
    12 months-18.3%
    12 months, with dividends-18.3%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years+15.8%+5.0%
    5 years-45.6%-11.5%
    Since Mar 2018+17.8%+1.9%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2020, when the price rose 157.0%, and its weakest was 2022, when it fell 48.9%.

    YearCloseChange
    2026 through Oct 2026$18.19-23.7%
    2025$23.83+60.0%
    2024$14.89-22.0%
    2023$19.10-7.6%
    2022$20.68-48.9%
    2021$40.47+55.9%
    2020$25.96+157.0%
    2019$10.10-6.2%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 25.8% below its 50-day average of $22.11 and 32.8% below its 200-day average of $24.42.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$16.40
    50-day average$22.11-25.8%
    200-day average$24.42-32.8%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 66.0%.

    MeasureValue
    1-year beta1.59
    Largest fall, 1 year-48.1%
    Largest fall, 3 years-66.0%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About RCUS

    What is RCUS's 1-year price change?

    Arcus Biosciences's price fell 18.3% over the past 12 months. With dividends included, the 12-month total return was -18.3%.

    What is RCUS's 5-year price change?

    Arcus Biosciences's month-end price fell 45.6% over the 5 years through Oct 2026, a compound annual decline of 11.5%. These figures leave out dividends.

    What is RCUS's beta?

    Arcus Biosciences's 1-year beta against the S&P 500 is 1.59, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 48.1%.

    Is the RCUS chart free?

    Yes. Advanced Charting for RCUS is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.